Parenteral Drug Association

What Parenteral Drug Association does

Parenteral Drug Association (PDA) is a 501(c)(3) nonprofit professional association founded in 1946 and headquartered in Bethesda, Maryland. It serves as the recognized authoritative technical body for pharmaceutical and biopharmaceutical manufacturing science, with more than 10,500 individual members across 26 chapters in North America, Europe, Asia Pacific, and South America. Its primary constituents are pharmaceutical manufacturers (sterile injectables, biologics, vaccines, ATMPs), regulatory authorities, suppliers, and academic institutions working on GMP compliance, sterility assurance, and aseptic processing.

PDA's core product is a content library of Technical Reports, Points to Consider documents, ANSI/PDA consensus Standards, Manufacturing Technology Guides, and industry benchmarking Surveys, covering topics from process validation and contamination control to quality risk management and temperature-controlled distribution. The organization complements publishing with hands-on training delivered through the Training and Research Institute in Bethesda, a global conference portfolio (PDA Week, PDA/FDA Joint Regulatory Conference, Pharmaceutical Microbiology Conference, Universe of Pre-Filled Syringes), and peer-reviewed publications including the PDA Journal and PDA Letter newsletter. Revenue is generated from membership dues, conference attendance and sponsorship, paid training courses, publication sales, and certification programs, with no public financial disclosures as a nonprofit entity.

PDA operates through three legal entities: Parenteral Drug Association, Inc. (USA), PDA Europe gemeinnuetzige GmbH (Berlin, founded 2006), and PDA Asia Pacific (Singapore, founded 2019), supported by the affiliated PDA Foundation for Pharmaceutical Education, Training and Research. Its strategic differentiation rests on long-standing regulatory engagement — particularly the co-branded PDA/FDA Joint Regulatory Conference and active comment-letter process — and a Board of Directors drawn from senior quality and regulatory leadership at Eli Lilly, Merck, GSK, Novo Nordisk, Bristol-Myers Squibb, West Pharmaceutical Services, and other major manufacturers.

Name

Parenteral Drug Association

Legal name

Parenteral Drug Association, Inc.

Website

https://pda.org

Company type

Private

Founded year

1946

Operating status

Operating

Headcount range

11–50 employees

Short description

Parenteral Drug Association is a 501(c)(3) nonprofit professional association, founded 1946, that provides technical reports, ANSI consensus standards, training, and conferences to 10,500+ pharmaceutical manufacturing professionals worldwide for GMP compliance, sterility assurance, and aseptic processing.

Ownership category

akta.pro rank

Headquarters

HQ city

Bethesda

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Distribution channels3 records

Marketing channels6 records

Core offering

PDA is a nonprofit professional association that publishes Technical Reports, Points to Consider documents, ANSI/PDA Standards, Books, and industry Surveys providing scientific and regulatory guidance for pharmaceutical and biopharmaceutical manufacturing. It complements its publications with paid training courses at the Training and Research Institute, certification programs (PDA 100, PDA 102), and global conferences including PDA Week and the PDA/FDA Joint Regulatory Conference. The organization sustains its work through membership dues, publication sales, and event fees.

Product overview

The Parenteral Drug Association is a professional organization that serves as the leading global provider of science, technology, and regulatory information for the pharmaceutical and biopharmaceutical industry. PDA offers a portfolio of publications including Technical Reports, Points to Consider documents, ANSI/PDA Standards, and industry Surveys that provide guidance on GMP compliance, aseptic processing, contamination control, and quality systems. The organization complements its publications with Training Courses delivered through the Training and Research Institute and global conferences such as PDA Week and the PDA/FDA Joint Regulatory Conference. Additional offerings include the PDA Journal for peer-reviewed research, the PDA Letter newsletter for regulatory news, and specialized workshops addressing topics like AI in pharmaceutical manufacturing and Annex 1 implementation.

Differentiator

Problem solved

Functional benefit

Products and services

• Technical Report No. 60 (Revised 2026): Process Validation: A Lifecycle Approach Revised PDA Technical Report providing updated guidance on process validation as a lifecycle approach for pharmaceutical manufacturers, aligning with FDA and EMA expectations.
• Technical Report No. 74 (Revised 2026): Reprocessing and Reworking of Biologicals Revised PDA Technical Report covering reprocessing and reworking procedures for biological products.
• Technical Report No. 56 (Revised 2026): Application of Phase-Appropriate Quality Systems and GMP to Biological Drug Substance Development Comprehensive update to foundational PDA Technical Report for GMP-compliant development of biological drug substances, providing phase-appropriate guidance across preclinical, clinical, and commercial stages.
• Technical Report No. 72: Passive Thermal Protection Systems for Global Distribution New PDA Technical Report providing qualification and operational guidance for passive thermal protection systems used in temperature-controlled distribution of pharmaceutical and biological products.
• Aseptic Processing and Sterilizing Filtration Documents (New Releases) A foundational set of three PDA documents — a Manufacturing Technology Guide, a revised process simulation report, and a revised sterilizing filtration report — aimed at improving aseptic processing and sterilizing filtration practices.
• PDA Technical Reports
• PDA Points to Consider Documents Guidance documents addressing specific pharmaceutical manufacturing topics such as ATMPs, aseptic processing, restricted access barrier systems, aging facilities, and remote/hybrid GMP/GDP audits; available individually or as a series.
• ANSI/PDA Standards Consensus standards developed jointly with ANSI covering quality risk management, cryopreservation of cells, filter ratings, and purchasing controls for pharmaceutical and biopharmaceutical industries.
• PDA Surveys Industry benchmarking surveys covering topics such as PUPSIT, transportation validation, EU GMP Annex 1 implementation, single-use systems, and visual inspection practices.
• PDA Books Technical publications covering pharmaceutical microbiology, quality risk management, GMP validation, contamination control, cleaning validation, and digital transformation for biopharmaceutical manufacturing.
• PDA Training Courses Expert-led hands-on training programs covering aseptic processing, quality management, biotechnology, pharmaceutical microbiology, visual inspection, and validation, available in-person across the Americas, Europe, and online.
• PDA Conferences and Workshops Industry conferences and workshops including PDA Week, PDA/FDA Joint Regulatory Conference, Pharmaceutical Microbiology Conference, Universe of Pre-Filled Syringes Conference, and topic-specific workshops on Annex 1, AI in manufacturing, and bioprocess solutions.
• PDA Journal Peer-reviewed scientific journal publishing research on pharmaceutical science, manufacturing technology, and regulatory affairs.
• PDA Letter Newsletter publication providing regulatory news, industry insights, and commentary on pharmaceutical manufacturing and supply chain topics.
• PDA Training and Research Institute (TRI) Physical training facility located in Bethesda, Maryland providing hands-on courses in pharmaceutical manufacturing, quality control, and sterility assurance, including certificate programs PDA 100 (Aseptic Processing) and PDA 102 (Environmental Monitoring).

Quantifiable outcome

• Technical Reports reflect current regulatory expectations from U.S. FDA and European Medicines Agency to help manufacturers achieve consistent, compliant, and high-quality outcomes
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• U.S. Food and Drug Administration (FDA)coreStrategic or Co-development Partner · 14 September 2026The PDA/FDA Joint Regulatory Conference is a flagship annual event focused on CGMP compliance, quality systems, risk-based manufacturing, and quality oversight throughout the product lifecycle. Features real-world case studies and international regulatory collaboration efforts. Glenn Wright, PDA President & CEO, and Paul Balcer, FDA conference co-chair, highlighted the event's role in advancing quality systems and supporting voluntary industry compliance.
• American National Standards Institute (ANSI)coreStrategic or Co-development PartnerPDA and ANSI collaborate to develop consensus standards for the pharmaceutical and biopharmaceutical industry. Joint ANSI/PDA Standards address topics including quality risk management, cryopreservation of cells, filter rating, and purchasing controls.
• AM InstrumentsminorOthersPartner in PDA-hosted sustainable packaging workshop at Pharmapack Europe 2026 in Paris. Workshop explored ecodesign for pharmaceutical devices and regulatory compliance in pharmaceutical packaging.
• Alliance to ZerominorOthersPartner in PDA-hosted sustainable packaging workshop at Pharmapack Europe 2026 in Paris. Workshop explored ecodesign for pharmaceutical devices and regulatory compliance in pharmaceutical packaging.
• Inductio AGminorOthersPartner in PDA-hosted sustainable packaging workshop at Pharmapack Europe 2026 in Paris. Workshop explored ecodesign for pharmaceutical devices and regulatory compliance in pharmaceutical packaging.

Scale indicators3 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• American Society of Health-System Pharmacists (ASHP): ASHP is a much larger US-focused pharmacist membership association with overlapping interest in sterile compounding standards, injectable drug safety, and USP <797>/<800> guidance, making it a broader incumbent that touches PDA's domain from the pharmacy/clinical side.
• Pharmaceutical Research and Manufacturers of America (PhRMA): PhRMA is the US pharmaceutical industry's principal lobbying and policy trade association representing large innovator companies, with broader policy remit than PDA but overlapping membership at the executive level across major manufacturers.
• ASTM International: ASTM is a much larger global standards development organization that produces some pharmaceutical/biopharmaceutical standards through ANSI-accredited processes; comparable as a peer in the standards-development niche but with a far broader industrial scope.
• Biotechnology Innovation Organization (BIO): BIO is the largest US biotech trade association, primarily focused on policy, advocacy, and industry events with a much broader scope than PDA but with member overlap among biopharmaceutical manufacturers that PDA's manufacturing-focused content serves.

Direct peers

• Drug Information Association (DIA): DIA is a neutral, global, member-driven nonprofit that brings together stakeholders in drug development, regulation, and safety through conferences, training, and publications - highly comparable to PDA in model (nonprofit, conferences, training, publications) but focused on drug development/regulatory affairs rather than manufacturing science.
• International Society for Pharmaceutical Engineering (ISPE): ISPE is a global nonprofit membership association serving pharmaceutical manufacturing professionals with conferences, training, publications, and guidance on GMP, facilities, and quality - the closest direct peer to PDA, with overlapping but broader scope (includes facilities engineering, supply chain, and oral solid dose in addition to sterile/parenteral).

Emerging players

• GMP Publishing (Maas & Peither AG): GMP Publishing is a German-based publisher specializing in GMP compliance guides, pharmaceutical regulatory handbooks, and related training content that competes with PDA's Technical Reports and Books product lines in the German-speaking European market.
• ECA Academy (European Compliance Academy): ECA Academy is a European-based GMP compliance training and publications organization that competes with PDA in conferences, training courses, and guidance documents for pharmaceutical manufacturing professionals in Europe.

Regional players

• Parenteral and Enteral Nutrition Society (PENG) / ASPEN: ASPEN is a US-based clinical/nutrition-focused membership society that touches parenteral nutrition compounding standards; narrower clinical focus than PDA but overlapping topical interest in parenteral preparation safety and quality.
• Pharmaceutical Quality Group (PQG): PQG is a UK-based professional association for pharmaceutical quality professionals offering training, publications, and conferences, directly comparable to PDA in scope but focused primarily on the UK/European pharmaceutical market.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/pdaonline

Revenue estimate

Valuation estimate

Number of profiles

Profiles19 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parenteral Drug Association